Richard Collier's most recent trade in Prothena Corporation plc was a trade of 20,183 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Prothena Corporation plc | Richard T. Collier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 20,183 | 20,183 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Richard T. Collier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Richard Collier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Richard Collier | Director | Sale of securities on an exchange or to another person at price $ 52.67 per share. | 05 Jan 2023 | 5,000 | 1,219 (0%) | 0% | 52.7 | 263,350 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Richard Collier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.41 per share. | 05 Jan 2023 | 5,000 | 6,219 (0%) | 0% | 6.4 | 32,050 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Richard Collier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Richard Collier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.41 per share. | 05 Dec 2022 | 5,000 | 6,219 (0%) | 0% | 6.4 | 32,050 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Richard Collier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2022 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Richard Collier | Director | Sale of securities on an exchange or to another person at price $ 60.28 per share. | 05 Dec 2022 | 1,915 | 4,304 (0%) | 0% | 60.3 | 115,429 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Richard Collier | Director | Sale of securities on an exchange or to another person at price $ 65.02 per share. | 05 Dec 2022 | 949 | 1,219 (0%) | 0% | 65.0 | 61,701 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Richard Collier | Director | Sale of securities on an exchange or to another person at price $ 61.13 per share. | 05 Dec 2022 | 913 | 3,391 (0%) | 0% | 61.1 | 55,809 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Richard Collier | Director | Sale of securities on an exchange or to another person at price $ 63.83 per share. | 05 Dec 2022 | 647 | 2,168 (0%) | 0% | 63.8 | 41,296 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Richard Collier | Director | Sale of securities on an exchange or to another person at price $ 62.71 per share. | 05 Dec 2022 | 576 | 2,815 (0%) | 0% | 62.7 | 36,121 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Richard Collier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.41 per share. | 07 Nov 2022 | 5,000 | 6,219 (0%) | 0% | 6.4 | 32,050 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Richard Collier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 5,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Richard Collier | Director | Sale of securities on an exchange or to another person at price $ 55.71 per share. | 07 Nov 2022 | 2,688 | 2,045 (0%) | 0% | 55.7 | 149,740 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Richard Collier | Director | Sale of securities on an exchange or to another person at price $ 54.74 per share. | 07 Nov 2022 | 1,486 | 4,733 (0%) | 0% | 54.7 | 81,348 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Richard Collier | Director | Sale of securities on an exchange or to another person at price $ 56.89 per share. | 07 Nov 2022 | 826 | 1,219 (0%) | 0% | 56.9 | 46,995 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Richard Collier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2022 | 5,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Richard Collier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.41 per share. | 05 Apr 2022 | 5,000 | 6,219 (0%) | 0% | 6.4 | 32,050 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Richard Collier | Director | Sale of securities on an exchange or to another person at price $ 39.18 per share. | 05 Apr 2022 | 2,631 | 3,588 (0%) | 0% | 39.2 | 103,073 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Richard Collier | Director | Sale of securities on an exchange or to another person at price $ 39.66 per share. | 05 Apr 2022 | 2,369 | 1,219 (0%) | 0% | 39.7 | 93,954 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Richard Collier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Richard Collier | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2021 | 15,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Richard Collier | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2021 | 15,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Richard Collier | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2021 | 12,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Richard Collier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 9,803 | 9,803 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Richard Collier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 8,426 | 8,426 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Richard Collier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 6,315 | 6,315 | - | - | Employee Stock Option (Right to Buy) |